Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Iran helicopter crash that killed President Raisi could reverberate across the Middle East
JERUSALEM (AP) — The helicopter crash in which Iranian President Ebrahim Raisi, the country’s foreig2024-05-21Indian cyclists David Beckham, Ronaldo catch eyes at Asiad
(Xinhua) 11:15, September 28, 2023HANGZHOU, Sept. 27 (Xinhua) -- Two young Indian cyclists found the2024-05-21Attaining Wealth by Growing Popular Guavas
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Weifang: A City of Crafts and Folk Arts
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21Lynn Williams breaks NWSL goal
Lynn Williams scored her 79th league goal, becoming the National Women’s Soccer League all-time scor2024-05-21Caring for Cranes Meticulously
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment